Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocarnitine Supplementation for Motor Function Maintenance in Parkinson's Disease with Carnitine Deficiency
jRCT1031250693Completed
- Sponsor
- Juntendo University Nerima Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levocarnitine in Parkinson's disease (PD), Sarcopenia and carnitine deficiency, sponsored by Juntendo University Nerima Hospital. Primary endpoints: Number of falls over one-month periods at week 32, Change in L3 skeletal muscle index (SMI) at week 16 and 1 more. Started Jul 2022; status: completed.
02
Drugs
levocarnitine
03
Conditions
Parkinson's disease (PD)Sarcopeniacarnitine deficiency
Beyond the preview
Go deeper on jRCT1031250693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250693.